Assessment of Proliferative Potential of Meningiomas Using PCNA LI and AgNOR Counts

Indian Journal of Pathology and Microbiology

Volumn 41, Issue 3, 1998, Pages 323-330

  Sudha, Krishn ^a   Karak, Asis Kumar ^a   Sharma, Mehar Chand ^a   Mathur, Meera ^a   Sarkar, Chitra ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

AgNOR count; Intracranial tumours; Meningioma; PCNA LI; Prognosis

Indexed keywords

CYCLINE;

ADOLESCENT; ADULT; ARTICLE; CELL DIVISION; CHILD; CHROMOSOME NOR; FEMALE; HUMAN; MALE; MENINGIOMA; PATHOLOGY; RECURRENT DISEASE; SEXUAL DEVELOPMENT;

ADOLESCENT; ADULT; CELL DIVISION; CHILD; FEMALE; HUMANS; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; NUCLEOLUS ORGANIZER REGION; PROLIFERATING CELL NUCLEAR ANTIGEN; RECURRENCE; SEX CHARACTERISTICS;

EID: 0032113491     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Crone KR, Challa VR, Kute TE et al: The relationship between flow cytometric features and clinical behaviour of meningiomas. Neurosurg 23: 720-724, 1991.
2. Ironside JW, Battersby RDE, Lawry J, Looms RS, Day CA, Timperley WR: DNA in meningioma tissue and explant cell cultures. A flow cytometric study with clinicopathological correlates. J Neurosurg 66: 588-94, 1987
3. May PL, Broome JC, Lawry J, Burton RA, Batterby RDE: The prediction of recurrence of meningiomas: A flow cytometric study of paraffin-embedded archival material. J Neurosurg 71: 347-51, 1993.
4. Fukui M, Iwaki T, Sawa H Inone T, Takeshita I, Kitamura K: Proliferative activity of meningiomas as evaluated by Bromodeoxyuridine uptake examination. Acta Neurochir 81: 135-41, 1986.
5. Kharbanda K, Karak AK, Sarkar C, Dinda AK, Mathure M, Roy S: A sequential cell kinetic study of meningioma cells in primary explant culture using bromodeoxyuridine. J Neuro-oncol 16: 17-123, 1993.
6. Kharbanda K, Karak AK, Sarkar C, Dinda AK, Mathur M, Roy S: Prediction of biologic aggressiveness in human meningiomas: A Cell kinetic study using Bromodeoxyuridine in cells of primary explant culture. J Natl Can Inst 84: 194-95, 1992.
7. Hoshino T, Nagashima T, Judith JA, Wilson CV, David RL: Proliferative potential of human meningiomas of brain. A cell kinetic study with Bromodeoxyuridine. Cancer 58: 1466-72, 1986.
8. Karamitopoulou E, Perentes E, Diamantis I, Maraziotis T: Ki-67 immunoreactivity in human, central nervous system tumours: A study with MIB-1 monoclonal antibody on archival material. Acta Neuropathol 87: 47-54, 1994.
9. Giangaspero F, Doglioni C, Rivano MT, Pileri S, Gerdes J, Stan H: Growth fraction in human brain tumours defined by the monoclonal antibody Ki-67. Acta Nenropathol 74: 179-82, 1987.
10. Onta M, Iwaki T, Kitomoto TS, et al: MIB staining index and scoring of histological features in meningiomas Cancer 74: 3176-89, 1994.
11. Paulus W, Meixensberger J, Hofmann E, Roggendort W: Effect of embolisation of meningiomas on Ki-67 proliferation index. J Clin Pathol 46: 876-77, 1993.
12. Hsu DW, Pardo FS, Efird JT, Lingood RM, Hedley Whyte ET: Prognostic significance of proliferative indices in meningioma. J Nenropnthol Exp Neurol 53: 247-55, 1994.
13. Nakabayoshi H, Sakaguchi M, Katsuyama J, Hekuba A: Proliferative potential of meningiomas evaluated by proliferating cell nuclear antiger expression. J Nenro-oncol 24: 209-17, 1975.
14. Cobb MA, Husain M, Anderson BJ, Al-Mefty O: Significance of proliferating cell nuclear antigen in predicting recurrence of interacranical meningiomas. J Nenrosurg 84: 85-90, 1996.
15. Swa T, Kawano N, Kameya T, Ito H, Okha H, Yada K: Invasive meningiomas in relation to high proliferative potential. Noshuya-Byori 10: 63-67, 1993.
16. Zimmer C, Gottschalk J, Cervos NJ, Martin H, Beil M, Jautzte G: Proliferating cell nuclear antigen (PCNA) in atypical and malignant meningiomas. Pathol Res Pract 188: 951-8, 1992.
17. Bagni A, Botticelli A, Martinelli A, Azzoni P, Trentini GP: AgNOR Counts in recurrent and non recurrent meningliomas. Histopath 19: 465-67, 1991.
18. Orita T, Kajiwara K, Nishizaki T, Ikede N, Kamiryo T, Aoki H: Nucleolar organiser regions in meningioma. Neurosurg 26: 43-46, 1990.
19. Kleihues P, Burger PC, Scheithauer BW: Histological typing of tumours of the central nervous system. Springer Verlag, Berlin, New York, Lindon 1993.
20. Prelich G, Tan CK, Kostura M, et al: Functional identity of proliferating cell nuclear antigen and a DNA polymerase delta auxiliary protein. Nature 326: 517-520, 1987.
21. Bravo R, Frank R, Blundell PA, Macdonald-Bravo H: Cyclin/PCNA is the auxiliary protein of DNA polymerase delta. Nature 326: 515-17, 1987.
22. Prelich G, Kostura M, Daniel R, Marshak et al: The cell cycle regulated proliferating cell nuclear antigen is required for SV-40 DNA replication in vitro. Nature 326: 471-75, 1987.
23. Prelich G, Stillman B: Coordinated leading and legging strand synthesis during SV-40 DNA replication in vitro requires PCNA. Cell 53: 117-126, 1988.
24. Celis JE, Celis A: Cell cycle dependent variations in the distribution of the nuclear protein cyclin/proliferating cell nuclear antigen in cultured cells: Subdivision of S phase. Proc Natl Acad Sci 82: 3262-66, 1985.
25. Bravo R, Macdonald-Bravo H: Existance of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: Association with DNA replication sites. J Cell Biol 105: 1549-53, 1987.
26. Hall PA, Levison DA, Woods AL et al: Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin section. An index of cell proliferation with evidence of deregulated expression in some neoplasms. J Pathol 162: 285-94, 1990.
27. Shih YH, Kadota Y, Sato K, Sueyoshi N, Shirai T: Immunohistochemical expression of PCNA in interacranial glioma and meningiomas. Chung-Hua I H Sueh-Tsa-Chih-Taipei 53: 193-7, 1994.
28. Burns DK, Mickey BE, Bigio EH, White CL: Proliferating cell nuclear antigen (PCNA) expression in human gliomas and meningiomas. J Neuropathol Exp Neurol 51: 362, 1992.
29. Allegranza A, Girlando A, Arrigoni GL et al: Proliferating cell nuclear antigen expression in central nervous system neoplasms. Virchows Archiv A Pathol Anat 419: 417-23, 1991.
30. Kramitopoulou E, Perentes E, Melachrinou M, Maraziotis T: Proliferating cell nuclear antigen immunoreactivity in human central nervous system neoplasms. Acta Neuropath 85: 316-22, 1993.
31. Underwood JCE, Girl DD: Nucleolar organizing region as diagnostic determinents for malignancy. J Pathol 155: 95-96, 1988.
32. Crocker J, Boldy DAR, Egan MJ: How should we count AgNORS ? Proposals for a standarized approach. J Pathol 158: 185-88, 1989.